Up
| Most Recent
2004N-0355: Scientific Considerations
Related to Developing Follow-up Protein Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| NM1
|
|
|
| 08/11/2004
|
| FDA
|
| FDA
|
| 08/16/2004
|
| 50386-50388
|
| 11/12/2004
|
| pdf
|
| Public
Workshop will be held 9/14-15/04
|
|
| Signature:
|
| SHUREN, JEFFREY
|
|
|
|
|
|
| NCR1
|
|
|
| 09/01/2004
|
| FDA
|
| FDA
|
| 09/07/2004
|
| 54149-54149
|
|
|
| pdf
|
|
|
|
| Signature:
|
| William K. Hubbard
|
|
|
| C1
|
| 09/14/2004
|
| 09/14/2004
|
| Private
Industry
|
| Biogen Idec
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Kathleen Kelley
|
|
|
| EC1
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EC2
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EC3
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EC4
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J Leclair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| Leclair, J
|
|
|
| EC5
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J Leclair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| Leclair, J
|
|
|
| EC6
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EC7
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Mrs. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EC8
|
| 09/23/2004
|
| 09/22/2004
|
| Health Professional
|
| Ms. J LeClair
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| LeClair, J
|
|
|
| EMC1
|
| 09/22/2004
|
| 09/22/2004
|
| Device Industry
|
| Biotechnology
Industry Organization (BIO)
|
|
|
|
|
|
|
| text,
Attachment
|
|
|
|
| Signature:
|
| Jessica S. Oldham
|
|
|
| EMC2
|
| 09/22/2004
|
| 09/22/2004
|
| Individual
Consumer
|
| J. Leclair
|
|
|
|
|
|
|
|
|
|
|
|
|
| TS1
|
| 09/27/2004
|
| 09/22/2004
|
| Drug Industry
|
| Novartis
Pharmaceuticals Corporation (Novartis)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| David Drake
|
|
|
| EC9
|
| 10/19/2004
|
| 10/18/2004
|
| Drug Industry
|
| Pharmaceutical
Scientist Inc
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| Niazi, Sarfaraz K.
|
|
|
| TR1
|
| 10/26/2004
|
| 10/26/2004
|
| Federal
Government
|
| Transcripts
|
|
|
|
|
|
|
| tr01,
tr02, tr03,
tr04, tr05,
tr06
|
| Workshop
Scientific considerations related to developing following-on
protein products Dockets No. 2004N- 0355 9/14-15/04
|
|
|
| Signature:
|
| Transcripts
|
|
|
|
|
|
|
|
|
|
| EXT1
|
| 11/08/2004
|
| 11/08/2004
|
| Association
|
| Biotechnology
Industry Organization (BIO)
|
|
|
|
|
|
|
| htm
|
|
|
|
| Signature:
|
| Sara Radcliffe, MPH
| |
|
| C2
|
| 11/12/2004
|
| 11/11/2004
|
| Drug Industry
|
| Genentech, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert L. Garnick, PhD
|
|
|
| EC10
|
| 11/12/2004
|
| 11/11/2004
|
| Drug Industry
|
| Rakoczy Molino Mazzochi Siwik LLP
|
|
|
|
|
|
|
| htm
|
|
|
|
| Signature:
|
| Siwik, Christine
|
|
|
| C3
|
| 11/12/2004
|
| 11/12/2004
|
| Drug Industry
|
| Amgen, Inc. (Amgen)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Kenneth Seamon, PhD
|
|
|
|
|
| C4
|
| 11/12/2004
|
| 11/12/2004
|
| Drug Industry
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Caroline J. Loew, PhD
|
|
|
| C5
|
| 11/12/2004
|
| 11/12/2004
|
| Drig Industry
|
| Sicor, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Suzanne M. Sensabaugh,MS,MBA
|
|
|
| C6
|
| 11/14/2004
|
| 11/12/2004
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Frederick W. Telling, PhD
|
|
|
| EMC3
|
| 11/12/2004
|
| 11/12/2004
|
| Assocaition
|
| Plasma Protein Therapeutics Assn (PPTA)
|
|
|
|
|
|
|
| pdf
txt
|
|
|
|
| Signature:
|
| Mary Gustafson
|
|
|
| EMC4
|
| 11/12/2004
|
| 11/12/2004
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Frederick W. Telling, PhD
|
|
|
| EC11
|
| 11/15/2004
|
| 11/12/2004
|
| Drug Industry
|
| Novartis Pharmaceuticals Corporation
|
|
|
|
|
|
|
| html
|
|
|
|
| Signature:
|
| Hukkelhoven, Mathias
|
|
|
| C7
|
| 11/17/2004
|
| 11/12/2004
|
| Association
|
| Plasma Protein Therapeutics Assn (PPTA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Mary Gustafson
|
|
|
| C8
|
| 11/24/2004
|
| 11/23/2004
|
| Drug Industry
|
| Schering Corporation (Schering Plough)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Ronald Garutti, MD
|
|
|
| C9
|
| 12/09/2004
|
| 12/09/2004
|
| Drug Association
|
| Generic Pharmaceutical Assn (GPhA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Kathleen Jaeger, Esq
|
|
|
| C10
|
| 12/15/2004
|
| 12/15/2004
|
| Drug Industry
|
| Barr Laboratories et al.
|
|
|
|
|
|
|
| htm
|
|
|
|
| Signature:
|
| Christine J. Siwik
|
|
|
| EMC5
|
| 12/14/2004
|
| 12/14/2004
|
| Drug Industry
|
| Biotechnology Industry Organization (BIO)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Sara Radcliffe, MPH
|
|
|
| EMC6
|
| 01/05/2005
|
| 01/05/2005
|
| Association
|
| Plasma Protein Therapeutics Assn (PPTA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Mary Gustafson
|
|
|
| C11
|
| 01/10/2005
|
| 01/06/2005
|
| Association
|
| Plasma Protein Therapeutics Assn (PPTA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Mary Gustafson
|
|
|
| C12
|
| 02/08/2005
|
| 02/07/2005
|
| Drug Industry
|
| Hoffman-La Roche, Inc. (Roche)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Michael Doherty
|
|
|
| EMC7
|
| 02/07/2005
|
| 02/07/2005
|
| Private Industry
|
| Hoffman-La Roche, Inc. (Roche)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| John Talian, PhD
|
|
|
| NEC1
|
|
|
| 02/11/2005
|
| FDA
|
| FDA
|
| 02/16/2005
|
| 7950-7951
|
| 03/16/2005
|
| txt | pdf
|
|
|
|
| Signature:
|
| Jeffrey Shuren
|
|
|
| SUP1
|
| 03/16/2005
|
| 03/16/2005
|
| Association
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Caroline J. Loew
|
|
|
| C13
|
| 03/16/2005
|
| 03/15/2005
|
| Drug Industry
|
| Novo Nordisk Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Jim Shehan and Mary Ann McElligott
|
|
|
| C14
|
| 03/17/2005
|
| 03/16/2005
|
| Drug Industry
|
| Genentech, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert L. Garnick, PhD
|
|
|
Top | Up
| Most Recent
Page last updated April 25, 2006 kk |